Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Change in Cash: 2015-2022

Historic Change in Cash for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Dec 2022 value amounting to $13.3 million.

  • Avadel Pharmaceuticals' Change in Cash rose 277.80% to $13.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $23.3 million, marking a year-over-year increase of 210.75%. This contributed to the annual value of $20.2 million for FY2024, which is 147.19% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Change in Cash of $13.3 million as of Q4 2022, which was up 101.40% from $6.6 million recorded in Q3 2022.
  • Avadel Pharmaceuticals' 5-year Change in Cash high stood at $63.7 million for Q1 2020, and its period low was -$28.4 million during Q2 2018.
  • For the 3-year period, Avadel Pharmaceuticals' Change in Cash averaged around $5.4 million, with its median value being -$79,000 (2022).
  • Per our database at Business Quant, Avadel Pharmaceuticals' Change in Cash plummeted by 352.28% in 2018 and then soared by 20,795.74% in 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Change in Cash (Quarterly) stood at -$8.5 million in 2018, then skyrocketed by 63.66% to -$3.1 million in 2019, then crashed by 268.15% to -$11.4 million in 2020, then spiked by 34.48% to -$7.5 million in 2021, then soared by 277.80% to $13.3 million in 2022.
  • Its Change in Cash was $13.3 million in Q4 2022, compared to $6.6 million in Q3 2022 and -$6.7 million in Q2 2022.